Arbutus Biopharma Corporation
ABUS
$2.80
$0.093.32%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 126.00M | 134.18M | 152.48M | 146.73M | 146.91M |
| Total Receivables | 1.78M | 2.17M | 2.61M | 3.26M | 1.35M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.25M | 5.26M | 3.70M | 2.86M | 2.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 132.03M | 141.61M | 158.80M | 152.85M | 151.14M |
|
|
|||||
| Total Current Assets | 132.03M | 141.61M | 158.80M | 152.85M | 151.14M |
| Net Property, Plant & Equipment | 6.09M | 6.54M | 6.96M | 6.52M | 6.81M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 3.00K | 11.00K | 62.00K | 103.00K |
| Total Assets | 144.40M | 158.64M | 176.82M | 191.22M | 195.42M |
|
|
|||||
| Total Accounts Payable | 3.22M | 2.26M | 1.04M | 2.46M | 3.52M |
| Total Accrued Expenses | 7.05M | 7.55M | 7.76M | 7.20M | 12.51M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 425.00K | 412.00K | 397.00K | 446.00K | 372.00K |
| Total Finance Division Other Current Liabilities | 11.79M | 12.11M | 15.33M | 15.06M | 16.46M |
| Total Other Current Liabilities | 11.79M | 12.11M | 15.33M | 15.06M | 16.46M |
| Total Current Liabilities | 22.49M | 22.32M | 24.53M | 25.15M | 32.86M |
|
|
|||||
| Total Current Liabilities | 22.49M | 22.32M | 24.53M | 25.15M | 32.86M |
| Long-Term Debt | 6.95M | 8.11M | 8.79M | 9.38M | 10.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.34M | 1.50M | 1.65M | 1.67M | 1.82M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.60M | 7.37M | 7.17M | 11.10M | 13.53M |
| Total Liabilities | 38.38M | 39.30M | 42.13M | 47.31M | 58.57M |
|
|
|||||
| Common Stock & APIC | 1.43B | 1.43B | 1.42B | 1.41B | 1.39B |
| Retained Earnings | -1.28B | -1.26B | -1.24B | -1.22B | -1.20B |
| Treasury Stock & Other | -48.42M | -48.88M | -49.47M | -49.63M | -50.49M |
| Total Common Equity | 106.02M | 119.34M | 134.69M | 143.92M | 136.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 106.02M | 119.34M | 134.69M | 143.92M | 136.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 106.02M | 119.34M | 134.69M | 143.92M | 136.85M |
|
|
|||||
